肝硬化
Liver cirrhosis.
作者信息
Williams E J, Iredale J P
机构信息
University Medicine, Southampton General Hospital, UK.
出版信息
Postgrad Med J. 1998 Apr;74(870):193-202. doi: 10.1136/pgmj.74.870.193.
Abstract
Liver fibrosis and its related complications continue to represent a significant worldwide healthcare burden. Over the past decade there has been considerable improvement in our understanding of the cellular mechanisms and pathophysiology underlying hepatic fibrosis. This greater insight into the relevant basic sciences may lead to the development of novel treatment strategies designed to block the fibrogenic cascade or even enhance matrix degradation. In addition, there have been significant advances in the management of the complications of cirrhosis, with specific treatments now available for some conditions. Perhaps most notably, liver transplantation is now a highly successful treatment for end-stage liver disease and should be considered in all patients with chronic liver disease.
摘要
肝纤维化及其相关并发症仍然是全球重大的医疗负担。在过去十年中，我们对肝纤维化潜在的细胞机制和病理生理学的理解有了显著进步。对相关基础科学的更深入了解可能会促使开发出旨在阻断纤维化级联反应甚至增强基质降解的新型治疗策略。此外，肝硬化并发症的管理也取得了重大进展，现在针对某些病症有了特定的治疗方法。也许最值得注意的是，肝移植现在是治疗终末期肝病的一种非常成功的方法，所有慢性肝病患者都应考虑进行肝移植。
相似文献
1
Liver cirrhosis.肝硬化
Postgrad Med J. 1998 Apr;74(870):193-202. doi: 10.1136/pgmj.74.870.193.
2
Management of end-stage liver disease.终末期肝病的管理。
Med Clin North Am. 2014 Jan;98(1):119-52. doi: 10.1016/j.mcna.2013.09.006. Epub 2013 Oct 30.
3
Management of patients with cirrhosis awaiting liver transplantation.肝硬化患者等待肝移植的管理。
Gut. 2011 Mar;60(3):412-21. doi: 10.1136/gut.2009.179937. Epub 2010 Dec 30.
4
[Therapy of liver cirrhosis. Managing complications with fingertip control].[肝硬化的治疗。通过精准控制管理并发症]
MMW Fortschr Med. 2001 Jul 5;143(26-27):34-7.
5
[Therapy of liver cirrhosis].[肝硬化的治疗]
Nihon Naika Gakkai Zasshi. 1992 Mar 10;81(3):297-301.
6
Management of patients with advanced liver cirrhosis.晚期肝硬化患者的管理
Nurs Stand. 2006;21(11):48-56; quiz 58. doi: 10.7748/ns2006.11.21.11.48.c6384.
7
Managing cirrhosis in the geriatric patient.
Geriatrics. 1983 Nov;38(11):66-74.
8
Balloon-occluded retrograde transvenous obliteration: one step beyond obliteration of gastric varices.球囊闭塞逆行静脉栓塞术：超越胃静脉曲张栓塞的一步。
J Gastroenterol Hepatol. 2012 Jan;27(1):3-4. doi: 10.1111/j.1440-1746.2011.06954.x.
9
Presentation and complications associated with cirrhosis of the liver.肝硬化的临床表现及相关并发症。
Curr Med Res Opin. 2015 May;31(5):925-37. doi: 10.1185/03007995.2015.1021905.
10
[Therapy of liver cirrhosis].[肝硬化的治疗]
Minerva Med. 1972 Dec 26;63(93):5258-60.
引用本文的文献
1
[Not Available].[无可用内容]
Tunis Med. 2025 Jan 5;103(1):86-92. doi: 10.62438/tunismed.v103i1.5035.
2
Prevalence of Spontaneous Bacterial Peritonitis (SBP) in Hepatitis B (HBV), and Hepatitis C (HCV) Liver Cirrhosis: A Systematic Review and Meta-Analysis.乙型肝炎（HBV）和丙型肝炎（HCV）肝硬化患者自发性细菌性腹膜炎（SBP）的患病率：一项系统评价和荟萃分析
Healthcare (Basel). 2023 Jan 16;11(2):275. doi: 10.3390/healthcare11020275.
3
Ascites of Unexplained Origin: A Case Report.不明原因腹水：一例报告
Cureus. 2022 Mar 17;14(3):e23256. doi: 10.7759/cureus.23256. eCollection 2022 Mar.
4
Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.非侵入性肝纤维化指标对肝硬化患者门静脉高压的诊断效能
PLoS One. 2017 Aug 18;12(8):e0182969. doi: 10.1371/journal.pone.0182969. eCollection 2017.
5
Telomere shortening as genetic risk factor of liver cirrhosis.端粒缩短作为肝硬化的遗传危险因素。
World J Gastroenterol. 2015 Jan 14;21(2):379-83. doi: 10.3748/wjg.v21.i2.379.
6
Assessment of serum acylated ghrelin in children and adolescents with chronic liver diseases: relation to nutritional status.慢性肝病儿童及青少年血清酰化胃饥饿素的评估：与营养状况的关系
ScientificWorldJournal. 2014;2014:560516. doi: 10.1155/2014/560516. Epub 2014 Oct 14.
7
A mouse strain where basal connective tissue growth factor gene expression can be switched from low to high.一种可以将基础结缔组织生长因子基因表达从低切换到高的小鼠品系。
PLoS One. 2010 Sep 22;5(9):e12909. doi: 10.1371/journal.pone.0012909.
8
Antisocial behavioral syndromes and past-year physical health among adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.美国成年人中的反社会行为综合征与过去一年的身体健康状况：来自酒精及相关状况全国流行病学调查的结果
J Clin Psychiatry. 2008 Mar;69(3):368-80. doi: 10.4088/jcp.v69n0305.
9
The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection.乙肝病毒和丁型肝炎病毒感染所致肝硬化及肝细胞癌患者体内胃饥饿素、瘦素、肿瘤坏死因子-α和白细胞介素-6的水平
Mediators Inflamm. 2006;2006(4):78380. doi: 10.1155/MI/2006/78380.
10
In vivo effects of Chinese herbal recipe, Danshaohuaxian, on apoptosis and proliferation of hepatic stellate cells in hepatic fibrotic rats.中药复方丹芍化纤对肝纤维化大鼠肝星状细胞凋亡及增殖的体内作用
World J Gastroenterol. 2005 Jan 28;11(4):561-6. doi: 10.3748/wjg.v11.i4.561.
本文引用的文献
1
Pathogenesis of liver fibrosis.肝纤维化的发病机制。
Clin Sci (Lond). 1997 Feb;92(2):103-12. doi: 10.1042/cs0920103.
2
The treatment of chronic viral hepatitis.慢性病毒性肝炎的治疗
N Engl J Med. 1997 Jan 30;336(5):347-56. doi: 10.1056/NEJM199701303360507.
3
Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).纳多洛尔单独或与单硝酸异山梨酯联合用于肝硬化静脉曲张出血一级预防的随机试验。门静脉高压症的的特里维耶内托小组（GTIP）。
Lancet. 1996;348(9043):1677-81. doi: 10.1016/s0140-6736(96)05406-2.
4
Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.利巴韦林联合干扰素α治疗慢性丙型肝炎的长期疗效
Gastroenterology. 1996 Nov;111(5):1307-12. doi: 10.1053/gast.1996.v111.pm8898645.
5
Matrix turnover in fibrogenesis.
Hepatogastroenterology. 1996 Jan-Feb;43(7):56-71.
6
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.肝硬化难治性腹水和肝肾综合征的定义及诊断标准。国际腹水俱乐部。
Hepatology. 1996 Jan;23(1):164-76. doi: 10.1002/hep.510230122.
7
Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.《波士顿贝斯以色列医院医学研讨会。肝纤维化的细胞基础。机制与治疗策略》
N Engl J Med. 1993 Jun 24;328(25):1828-35. doi: 10.1056/NEJM199306243282508.
8
9
Hepatorenal syndrome. New perspectives in pathogenesis and treatment.肝肾综合征。发病机制与治疗的新视角。
Arch Intern Med. 1993 Sep 13;153(17):1957-67. doi: 10.1001/archinte.153.17.1957.
10
Transjugular intrahepatic portosystemic stent-shunt.经颈静脉肝内门体分流术
Br J Hosp Med. 1993;49(11):791-3, 796-7.
Zotero 插件